Background Treatment of hypercholesterolaemia in Asia is rarely evaluated on a large
scale, and data on treatment outcome are scarce. The Pan-Asian CEPHEUS study aimed to …

Background: Less than half of patients in Scandinavian societies achieve target cholesterol
values established by consensus coronary prevention panels. Methods and results: Using …

Background Although statins are widely used to reduce low density lipoprotein cholesterol
(LDL-C), there is little information about patient profiles, treatment patterns and goal …

This article provides a summary of the available lipid-lowering therapies in the UK and how
they fit into national guidelines. In addition, comparison is made between the current …

The aim of this prospective study was to evaluate the appropriateness of cholesterol
management in Swiss clinical practice according to the recommendations of Swiss Society …

Aim. To analyze changes in the pattern of lipid-lowering therapy (LLT) in outpatients with
stable coronary artery disease (SCAD) over the 7-year period. Material and methods. This …

Introduction The preventive effect of lipid lowering treatment in secondary prevention after
coronary heart disease (CHD) is well documented. In 2015, regional guidelines recommend …

Definite evidence has been established, that coronary patients benefit from appropriate
therapeutic control of risk profile, as recommended by several Guidelines. However, the …

ABSTRACT INTRODUCTION: INTRODUCTION: Numerous studies have shown that
lowering of low-density lipoprotein-cholesterol (LDL-C) reduces the risk of cardiovascular …

Aim: The Pan-Asian CEPHEUS study assessed low-density lipoprotein cholesterol (LDL-C)
goal attainment among patients under lipid-lowering therapy. We compared Korean and …